Neurocritical care constitutes a specialized medical domain dedicated to addressing and treating patients afflicted with critical neurological conditions. These conditions often entail severe injuries or diseases impacting the brain, spinal cord, or peripheral nerves, necessitating immediate and intensive medical attention. The principal objective of neurocritical care revolves around averting secondary brain damage and optimizing neurological function in individuals grappling with life-threatening neurological ailments. This entails meticulous monitoring of vital signs, neurological status, and intracranial pressure, alongside prompt interventions to forestall complications like cerebral edema, ischemia, or hemorrhage. Neurocritical care teams typically comprise multidisciplinary experts, including neurologists, neurosurgeons, critical care physicians, nurses, respiratory therapists, and pharmacists, collaborating synergistically to furnish comprehensive care to patients grappling with complex neurological disorders. Common conditions managed within neurocritical care units encompass traumatic brain injury, subarachnoid hemorrhage, ischemic and hemorrhagic stroke, status epilepticus, spinal cord injury, and severe neurological infections. Treatment modalities may entail neuroprotective measures, mechanical ventilation, intracranial pressure monitoring, vasopressor therapy, and neurosurgical interventions like decompressive craniectomy or clot evacuation. Neurocritical care also assumes a pivotal role in aiding patients through the acute phase of their illness and facilitating their transition to rehabilitation services or long-term care facilities. Additionally, neurocritical care research contributes to advancements in comprehending the pathophysiology of neurological diseases and devising innovative treatments to augment patient outcomes.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States